The negative polls come as the Congressional Budget Office estimates the bill would lead to 23 million more uninsured people. » Read More
Blue Cross and Blue Shield NC says it would have asked for just an 8.8 percent increase, and not almost 24 percent. » Read More
The Republican Obamacare replacement bill includes provisions that could allow insurers to eliminate essential health benefits in plans. » Read More
By: Bertha Coombs
UnitedHealth Group's Optum unit has signed a multiyear agreement with Merck to develop a better way to reimburse drugmakers. » Read More
One of the world’s richest men is worried that too much regulation will stop the world from controlling a major flu outbreak.
Your gut bacteria has been conditioned by your eating habits. It could be thwarting your weight-loss efforts.
Soon, a single flu shot-like injection at the doctor's office once every two months could help prevent HIV. NBCNews reports.
A mere 20 conditions appear responsible for over half of all medical expenditures in the United States.
About 30 million people stand to lose health coverage if Obamacare is repealed without a replacement.
Synergy Pharmaceuticals skyrocketed after the firm reported positive trial results for an irritable bowel syndrome drug.
The only way to be prepared and ready for the next epidemic is to make vaccines against agents that we know exist.
The effort echoes a similar ad-hoc project to copy climate change data before Trump becomes president.
After decades of victories in the battle against heart disease, health experts are now facing a stark truth: Progress has stalled.
About 6.4 million people signed up on the federal insurance exchange amid promises by Donald Trump to repeal the Affordable Care Act.
Clovis Oncology shares jumped 15 percent Monday after the FDA approved Rubraca (rucaparib), the company's advanced ovarian cancer drug.
Mylan said on Friday it launched the generic version of its life-saving EpiPen allergy treatment at a more than 50 percent discount.
Merck was awarded $2.54 billion in royalties by a jury in a patent lawsuit against Gilead Sciences over Gilead's hepatitis C drugs.
Inpatient stays rose more than 64 percent and emergency department visits jumped almost 100 percent from opioid misuse.
Controlling health costs is the underlying theme behind many of the issues highlighted in PwC's 11th annual report on health-care trends.
Two senators are questioning a surge in price of a key drug made by Pfizer used to treat opioid overdoses.
You're going to have Obamacare around for a while, says Peter Orszag, Lazard vice chairman talking about the future of the Affordable Care Act, how it will evolve over the years and which health care companies are at risk.
Alexion Pharmaceuticals' David Hallal will be replaced on an interim basis by David Brennan, former CEO of AstraZeneca.
The U.S. surgeon general on Thursday called for action to reduce the use of e-cigarettes among young people.
The American Academy of Actuaries said more insurers could bolt the market, and fewer people could end up being insured.
Get the best of CNBC in your inbox